Whittier Trust CO Of Nevada Inc Seagen Inc. Transaction History

Whittier Trust CO Of Nevada Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$191.51 - $216.16 $435,493 - $491,547	-2,274 Reduced 72.81%	849 $180,000
Q1 2023 Apr 21, 2023	SELL	$127.59 - $203.08 $6,889 - $10,966	-54 Reduced 1.7%	3,123 $632,000
Q4 2022 Jan 25, 2023	BUY	$117.37 - $139.17 $94,952 - $112,588	809 Added 34.16%	3,177 $0
Q3 2022 Oct 21, 2022	BUY	$135.27 - $180.11 $307,603 - $409,570	2,274 Added 2419.15%	2,368 $324,000
Q4 2020 Jan 29, 2021	BUY	$164.63 - $211.93 $15,475 - $19,921	94 New	94 $16,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.